Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Lung Volume Reduction Surgery Decreases Need for Oxygen Therapy

By HospiMedica International staff writers
Posted on 16 Sep 2008
In patients with severe chronic obstructive pulmonary disease (COPD), lung-volume reduction surgery (LVRS) improves arterial blood oxygenation and decreases the need for supplemental oxygen, according to a new study.

Researchers from the University of Washington (Seattle, WA, USA) analyzed data from 1,078 patients enrolled in the U.S. More...
national emphysema treatment trial (NETT)--a large multicenter, randomized clinical trial of maximal medical therapy compared with LVRS for severe emphysema. During the trial, the researchers collected arterial blood gas data, performed a standardized oxygen titration test, and asked patients about supplemental oxygen use at baseline and at different time points after LVRS or medical therapy in patients with severe COPD.

The results showed that although the treatment groups were nearly identical at baseline, significantly larger percentages of medical patients had insufficient arterial blood oxygenation (PaO2) of 55 mm Hg or less at each follow-up visit, compared with LVRS patients (22% versus 10% at six months; 22% versus 14% at 12 months; and 25% versus 15% at 24 months). Significantly more LVRS patients than medical patients had a PaO2 at 24 months that was improved or stable compared with baseline (65% versus 39%).

Twenty-four months after randomization, 53% of LVRS patients with PaO2 of 55 mm Hg or less at baseline showed an increase to a PaO2 of greater than 55 mm Hg compared with only 17% in the medical group. Furthermore, while fewer medical patients required oxygen for treadmill walking at baseline compared with surgical patients (46% versus 53%), more medical patients required oxygen for treadmill walking at six months (49% versus 33%), 12 months (50% versus 36%), and 24 months (52% versus 42%). The study was published in the August 15, 2008, issue of the American Journal of Respiratory and Critical Care Medicine.

"LVRS as performed in the NETT results in an improvement in oxygenation that is small but significant,” said lead author Joshua Benditt, M.D.; however, he added, "no factor predicting a shift from needing oxygen preoperatively to not needing oxygen postoperatively could be identified.”

In LVRS, 20-30% of the diseased portions of the lungs are removed so that there is more room for healthy lung tissue to expand and carry on gas exchange, as well as more space for the diaphragm to take on its normal shape and function. Since normally there is a vacuum between the ribs and the lungs (which helps the lungs expand and fill with air when the chest wall expands), the main complication of LVRS is an air leak, which causes the lungs to sag. Therefore, the staples used during surgery are reinforced with a bovine cardiac membrane to prevent these leaks, much like adding bias tape to cloth to prevent tearing while sewing.

Related Links:
University of Washington



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Bipolar Coagulation Generator
Aesculap
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.